REGENERO
Regenero specializes in the development and commercialization of innovative cellular therapies.
REGENERO
Status:
Active
Similar Organizations
MedCap Funds
MedCap Funds invests in the development and commercialization of medical technology companies.
TrioxBio
TrioxBio specializes in the development and commercialization of proprietary synthetic small molecules.
Current Employees Featured
More informations about "Regenero"
Meet Regeneron's Leadership Team
Our leadership team possesses deep and diverse industry knowledge, a passion for science and a shared commitment to help transform lives. Made up of our founding scientists, industry …See details»
Regeneron Canada: Push the Bounds of Science
Regeneron is a leading science and technology company dedicated to inventing, developing and commercializing life-transforming treatments for serious diseases. Our mission is to use the power of science to bring new medicines to …See details»
Regeneron: Our Culture and Values
Learn about Regeneron's culture, workplace and approach to corporate responsibility.See details»
Regeneron Pharmaceuticals - Wikipedia
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first produc…See details»
Regeneron - Leadership Team - The Org
The Leadership Team at Regeneron Pharmaceuticals is responsible for guiding the strategic direction and operational execution of the company.See details»
Regeneron - LinkedIn
At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize...See details»
Industrial Operations and Product Supply (IOPS)
Industrial Operations and Product Supply (IOPS) turns cutting-edge science into innovative biologic medicines to improve the lives of patients worldwide.See details»
Regeneron Commits $34 Million Over Five Years to Continue to …
Nov 13, 2023 · The renewed sponsorship builds on Regeneron and the Society's long-standing partnership to advance STEM education, including through Regeneron's $100 million, ten-year …See details»
Regeneron's Chief Executive Officer and Chief Scientific Officer …
Nov 25, 2013 · Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes …See details»
Regeneron: Improving the Lives of People with Serious …
Our robust pipeline spans eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neuromuscular diseases, infectious diseases and rare diseases. The Regeneron Genetics Center ® …See details»
Regeneron 2021 Year in Review | Life-changing Medicines
We make medicines that address serious medical conditions across multiple therapeutic areas. Our nine FDA-approved medicines are only the beginning of our quest to solve the human …See details»
Regeneron Pharmaceuticals | World Economic Forum
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, its unique ability …See details»
QA Investigation Specialist - careers.regeneron.com
Excel in a quality driven organization. Have an understanding of biologics manufacturing operations. ... Regeneron is an equal opportunity employer and all qualified applicants will …See details»
Regeneron Welcomes World Health Organization …
Regeneron Welcomes World Health Organization Recommendation for Use of REGEN-COVâ„¢ (casirivimab and imdevimab) to Treat COVID-19 • The WHO conditionally recommends …See details»
History of Regeneron Pharmaceuticals: 35 Years of Innovation
For 35 years, our mission has been to use the power of science to bring new medicines to patients. Learn more about our history of innovation in biotechnology.See details»
WHO backs Regeneron COVID-19 drug cocktail - UN News
Sep 24, 2021 · The Regeneron antibody drug cocktail – casirivimab and imdevimab – has been added to the World Health Organization’s (WHO) list of treatments for COVID-19 patients, the …See details»
WHO backs Regeneron COVID-19 drug cocktail as UN body calls …
Sep 23, 2021 · Sept 24 (Reuters) - A World Health Organization (WHO) panel on Friday recommended the use of Regeneron (REGN.O) and Roche's (ROG.S) COVID-19 antibody …See details»
Regeneron Corporate Responsibility Strategy & Goals
At Regeneron, we use our unique knowledge and expertise for the benefit of society, the economy and the environment. By addressing issues that matter most to our business and society, we …See details»
Subcutaneous REGEN-COV Antibody Combination to Prevent …
Aug 4, 2021 · REGEN-COV (previously known as REGN-COV2), a combination of the monoclonal antibodies casirivimab and imdevimab, has been shown to markedly reduce the …See details»
Regeneron Research and Business Development Collaborations
In the early days of the pandemic, Roche and Regeneron came together to develop, manufacture and distribute Regeneron’s investigational monoclonal antibody cocktail to treat and prevent …See details»